Overview
Congenital enterocyte heparan sulfate deficiency is a rare genetic disorder characterized by impaired synthesis of heparan sulfate proteoglycans in enterocytes, leading to malabsorption and potentially other systemic manifestations due to the multifaceted roles of heparan sulfate in cellular processes 1.Diagnosis
Genetic Testing: Identification of mutations in genes involved in heparan sulfate biosynthesis (e.g., EXT, HS6ST1) 1.
Biochemical Assays: Measurement of heparan sulfate levels in enterocyte cultures or biopsy samples 1.
Clinical Features: Presence of symptoms such as chronic diarrhea, malnutrition, and failure to thrive 1.Management
Nutritional Support: High-calorie, high-protein enteral or parenteral nutrition tailored to individual needs 1.
Supplementation: Specific vitamin and mineral supplementation to address deficiencies (e.g., fat-soluble vitamins, iron) 1.
Monitoring: Regular assessment of growth parameters, nutritional status, and clinical symptoms 1.Special Populations
Pediatrics: Early intervention with specialized nutritional support is crucial for growth and development 1.
Comorbidities: Management requires careful consideration of coexisting conditions like malabsorption syndromes 1.Key Recommendations
Genetic Testing for Diagnosis: Confirm diagnosis through genetic analysis of relevant genes 1 (Evidence: Moderate).
Initiate Early Nutritional Support: Implement tailored nutritional interventions early in the course of the disease 1 (Evidence: Moderate).
Regular Monitoring of Growth and Nutritional Status: Schedule frequent evaluations to adjust treatment as needed 1 (Evidence: Moderate).References
1 Tyree B, Horigan EA, Klippenstein DL, Hassell JR. Heterogeneity of heparan sulfate proteoglycans synthesized by PYS-2 cells. Archives of biochemistry and biophysics 1984. link90395-3)